MedCity has launched a new report to help people navigate the neuroscience research and innovation happening across the region. We spoke with neuroscientists at universities, pharmaceutical companies, research councils and charities, to find out about their research, initiatives, and what the future holds for translational neuroscience.

In 2015, Alzheimer’s disease and other dementias overtook ischaemic heart disease as the leading cause of death in England and Wales. However, recent advances in genetics, diagnostics and imaging have progressed scientists’ understanding of what causes a large number of neurodegenerative diseases. Many of these scientists reside within the greater south east of England, and the region has both breadth and depth in terms of neuroscience research.

Read our report here:

Turning progress in basic science into effective treatments still remains the challenge; however collaborative efforts will prove vital in ensuring scientific developments translate into improved patient care.

The ‘Golden Triangle’ is the world-leading life sciences cluster of Cambridge, London and Oxford, sitting at the heart of England’s greater south east. This cluster is home to cutting-edge scientific research and ground-breaking medical innovations, which benefit not only the surrounding communities but also has a global impact. With some of the oldest and most prestigious universities in the world and five out of the seven academic health sciences centres in the UK, this region is uniquely located to stimulate collaboration and turn discoveries into pioneering medical treatments, therapies and technological developments. New research centres in the area, such as The Francis Crick Institute, The Alan Turing Institute and the Translation & Innovation Hub at Imperial White City Campus, complement the thriving life sciences ecosystem, and aim to accelerate the translation of lab-based research into life-saving treatments.

Together we invite our colleagues across the globe to collaborate with industry and academia within the region to help drive forward future neuroscience innovations.

If you have any questions please get in touch with Sinead Kearns, Market Analyst, on